Enanta Pharmaceuticals, Inc. (ENTA)
13.60
-0.20
(-1.45%)
USD |
NASDAQ |
Aug 28, 16:00
13.58
-0.02
(-0.11%)
After-Hours: 20:00
Enanta Pharmaceuticals Total Liabilities (Quarterly) : 195.80M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 195.80M |
| March 31, 2026 | 198.12M |
| December 31, 2025 | 202.91M |
| September 30, 2025 | 228.00M |
| June 30, 2025 | 221.75M |
| March 31, 2025 | 229.46M |
| December 31, 2024 | 236.83M |
| September 30, 2024 | 261.99M |
| June 30, 2024 | 249.91M |
| March 31, 2024 | 247.44M |
| December 31, 2023 | 236.62M |
| September 30, 2023 | 253.10M |
| June 30, 2023 | 257.35M |
| March 31, 2023 | 57.07M |
| December 31, 2022 | 46.70M |
| September 30, 2022 | 59.26M |
| June 30, 2022 | 47.19M |
| March 31, 2022 | 48.24M |
| December 31, 2021 | 56.21M |
| September 30, 2021 | 41.43M |
| June 30, 2021 | 32.59M |
| March 31, 2021 | 31.74M |
| December 31, 2020 | 29.02M |
| September 30, 2020 | 35.21M |
| June 30, 2020 | 31.15M |
| Date | Value |
|---|---|
| March 31, 2020 | 27.51M |
| December 31, 2019 | 28.69M |
| September 30, 2019 | 28.55M |
| June 30, 2019 | 25.39M |
| March 31, 2019 | 25.37M |
| December 31, 2018 | 27.38M |
| September 30, 2018 | 21.49M |
| June 30, 2018 | 18.18M |
| March 31, 2018 | 21.25M |
| December 31, 2017 | 23.14M |
| September 30, 2017 | 26.18M |
| June 30, 2017 | 14.97M |
| March 31, 2017 | 12.95M |
| December 31, 2016 | 10.21M |
| September 30, 2016 | 11.42M |
| June 30, 2016 | 12.93M |
| March 31, 2016 | 15.18M |
| December 31, 2015 | 14.10M |
| September 30, 2015 | 9.856M |
| June 30, 2015 | 9.492M |
| March 31, 2015 | 21.67M |
| December 31, 2014 | 21.71M |
| September 30, 2014 | 6.559M |
| June 30, 2014 | 6.561M |
| March 31, 2014 | 6.631M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 68.16M |
| AbbVie, Inc. | 141.00B |
| Coherus Oncology, Inc. | 130.34M |
| BridgeBio Pharma, Inc. | 3.723B |
| RenovoRx, Inc. | 2.493M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 296.87M |
| Shareholders Equity (Quarterly) | 101.07M |
| Debt to Equity Ratio | 1.801 |
| Current Ratio | 3.759 |
| Net Debt Paydown Yield | 1.61% |